When nanotechnology and cancer research collide

Matt Faria is the inaugural Réjane Langlois Fellow in Biomedical Engineering. After switching from a career as a software engineer, Matt is now conducting research at the intersection of engineering, physics and biology. His work focuses on evaluating how nano-engineered materials target specific cells in the body. In the context of cancer treatment research, this would enable medical professionals to target only problematic cancer cells.

Matt Faria
Matt Faria, Réjane Langlois Fellow in Biomedical Engineering

His work pays tribute to Réjane Langlois, who left a gift in her Will to support research after surviving breast cancer, only to be later diagnosed with lung cancer.

Her legacy acknowledges the funding gap that sits between medical and pre-clinical research, and will provide Matt with the opportunity to deepen his research interests over a three-year period.

Réjane’s generous bequest is just one example of how donors who pledge a gift in their Will to the University will make a powerful and lasting impact on research and scholarship for generations to come.

I switched careers because I really wanted to do something that gave back to society. The really wonderful thing about the Fellowship is that it's enabled me to immerse myself in a research area that I'm very interested in, and continue to investigate and devote myself to that area for an extended period of time.

– Matt Faria, inaugural recipient of the Réjane Langlois Fellowship in Biomedical Engineering

View more stories of impact on our website.

Read More